Cargando…
Targeting Enox1 in tumor stroma increases the efficacy of fractionated radiotherapy
The goal of this investigation was to clarify the question of whether targeting Enox1 in tumor stroma would synergistically enhance the survival of tumor-bearing mice treated with fractionated radiotherapy. Enox1, a NADH oxidase, is expressed in tumor vasculature and stroma. However, it is not expre...
Autores principales: | Smith, Clayton A., Mont, Stacey, Traver, Geri, Sekhar, Konjeti R., Crooks, Peter A., Freeman, Michael L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363632/ https://www.ncbi.nlm.nih.gov/pubmed/27788492 http://dx.doi.org/10.18632/oncotarget.12845 |
Ejemplares similares
-
Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC
por: Traver, Geri, et al.
Publicado: (2020) -
Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
por: Hellevik, Turid, et al.
Publicado: (2014) -
ENOX2 Target for the Anticancer Isoflavone ME-143
por: Morré, D. James, et al.
Publicado: (2014) -
Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment
por: Sekhar, Konjeti R., et al.
Publicado: (2023) -
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)